HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS
    1.
    发明申请
    HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS 审中-公开
    杂环化合物和血栓素受体激活剂

    公开(公告)号:US20140051857A1

    公开(公告)日:2014-02-20

    申请号:US14064367

    申请日:2013-10-28

    摘要: A compound represented by the formula (1): wherein A is a nitrogen atom or CR4, B is an oxygen atom, a sulfur atom or NR9 (provided that when A is a nitrogen atom, B is not NH), R1 is a C2-14 aryl group, L1 is a bond, CR10R11, an oxygen atom, a sulfur atom or NR12, X is OR13, SR13 or NR14NR15, R2 is a hydrogen atom, a formyl group, a C1-10 alkyl group or the like, L2 is a bond or the like, L3 is a bond, CR17R18, an oxygen atom, a sulfur atom or NR19, L4 is a bond, CR20R21, an oxygen atom, a sulfur atom or NR22, Y is an oxygen atom, a sulfur atom or NR23, and R3 is a C2-14 aryl group, a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.

    摘要翻译: 由式(1)表示的化合物:其中A是氮原子或CR 4,B是氧原子,硫原子或NR 9(条件是当A是氮原子时,B不是NH),R1是C2 -14芳基,L1为键,CR10R11,氧原子,硫原子或NR12,X为OR13,SR13或NR14NR15,R2为氢原子,甲酰基,C1-10烷基等, L2是键或类似物,L3是键,CR17R18,氧原子,硫原子或NR19,L4是键,CR20R21,氧原子,硫原子或NR22,Y是氧原子,硫 原子或NR 23,并且R 3是该化合物或其溶剂合物的C2-14芳基,互变异构体,前药或药学上可接受的盐。